In February 2026, West Pharmaceutical Services’ Board authorized a new share repurchase program of up to US$1.00 billion with no expiration date and declared a regular quarterly dividend of US$0.22 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results